Project Grant R21AG095563
- Federal Grant Award Summary Auburn University received a $166,152 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective March 1, 2026 through February 28, 2029. This award supports research investigating the role of microRNA-1 (miR-1) in regulating pyruvate metabolism and skeletal muscle metabolic dysfunction in patients with peripheral artery disease (PAD). The project employs advanced molecular techniques including Argonaute enhanced...
- Summary of Federal Project Grant Award The National Institute on Aging (NIA) awarded a Project Grant totaling $1,308,220 under the Aging Research program (CFDA 93.866) to the University of Texas Health Science Center at Houston effective February 1, 2026, through December 31, 2030. The award funds research investigating the role of Enhancer of Zeste Homolog 2 (EZH2), an epigenetic modifier, in cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD). The research focuses on understanding...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant of $456,500 to The University of Texas Southwestern Medical Center (awarded May 15, 2026, with completion by April 30, 2028) under the Aging Research program (CFDA 93.866). This grant supports research into the genetic and molecular mechanisms underlying atherosclerosis, specifically investigating how the APOER2-R952Q mutation functions as a genetic modifier of premature cardiovascular disease. The...
- Federal Grant Award Summary The University of Texas at Austin received a $292,140 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective September 1, 2025, through May 31, 2030. This award supports research investigating how the accumulation of senescent cells (SNCs) and their senescence-associated secretory phenotypes (SASPs) impact osteocyte mechanobiology—the study of how bone cells sense and respond to mechanical forces. The project...
- Federal Project Grant Award Summary The University of Nebraska Medical Center (UNMC) received a $644,298 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective February 1, 2026, through January 31, 2031. The award funds comparative research on next-generation cell-based regenerative therapies for peripheral artery disease (PAD), specifically evaluating autologous adipose stromal vascular fraction (SVF) and SVF-derived exosomes...
- Federal Project Grant Award Summary The University of Texas at Austin received a $438,625 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) effective September 1, 2025, through August 31, 2027. The award funds research investigating the heterogeneity of interneuron vulnerability in aging and Alzheimer's disease using advanced ultraplex correlative light and electron microscopy (CLEM) techniques. The research aims to decode why certain...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $451,000 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded May 15, 2025, with a completion date of April 30, 2027. The award supports scientific research investigating estrogen modulation of chondrocyte mechanotransduction via the calcium-permeant mechanosensitive channels PIEZO1 and TRPV4. The research addresses documented sex-based health...
- Summary of Federal Project Grant Award The National Institute on Aging (CFDA 93.866 – Aging Research) awarded a Project Grant of $650,533 to the University of Texas Health Science Center at Houston, with an award date of February 1, 2026, and an ultimate completion date of January 31, 2031. This five-year research initiative investigates the contribution of intramural von Willebrand factor (VWF) to cerebrovascular dysfunction in amyloidosis, with particular focus on understanding VWF's role in...
- Federal Project Grant Award Summary Panorama Research Incorporated received a $354,000 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded on September 20, 2025, with an ultimate completion date of September 19, 2026. The grant funds the development of a novel therapeutic approach to address sarcopenia—the age-related loss of skeletal muscle mass, quality, and strength—which affects a significant portion of the elderly population, particularly those...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $451,000 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) for a two-year research project running from September 1, 2025 through August 31, 2027. The award supports research aimed at understanding and improving Chimeric Antigen Receptor (CAR) T cell production for elderly cancer patients by addressing age-related T cell dysfunction. The research will employ...
The University of Texas Health Science Center at Houston received a $429,000 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective July 1, 2026, through June 30, 2028. This exploratory research project investigates the intervention of endothelial senescence in limb muscle ischemia using exercise mimetics to address peripheral arterial disease (PAD), a major age-related cardiovascular condition characterized by vascular regression, muscle ischemia, and mitochondrial dysfunction. The research will employ unique transgenic mouse models, including muscle-specific estrogen-related receptor gamma (ERRG) transgenic mice and inducible endothelial-specific telomerase knockout mice, along with gene therapy approaches targeting estrogen-related receptors alpha and gamma (ERRA/ERRG) to evaluate whether activation of these receptors can reverse age-related muscle decline and mitigate geriatric PAD through exercise-mimicking mechanisms. The project deliverables include scientific research outputs examining the effect of exercise mimesis on preventing or reversing muscle decline and vascular senescence in aging populations. By elucidating the molecular pathways underlying age-related impairment in ischemic recovery and identifying potential therapeutic targets through exercise-mimicking interventions, this research aims to advance understanding of geriatric PAD pathophysiology and establish a foundation for non-surgical treatment approaches for older adults with limited access to conventional rehabilitation or endovascular surgery options.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $429.0k | 6/30/26 |